We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$28.5B
AUM Growth
-$1.64B
Cap. Flow
-$541M
Cap. Flow %
-1.9%
Top 10 Hldgs %
23.41%
Holding
1,182
New
104
Increased
354
Reduced
497
Closed
123

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$94.3M
2
MSFT icon
Microsoft
MSFT
+$65.5M
3
LLY icon
Eli Lilly
LLY
+$58.4M
4
NVDA icon
NVIDIA
NVDA
+$58M
5
ABBV icon
AbbVie
ABBV
+$43.8M

Top Sells

Rank Stock Value
1
SLAB icon
Silicon Laboratories
SLAB
+$84.9M
2
ATVI
Activision Blizzard
ATVI
+$78.4M
3
BAC icon
Bank of America
BAC
+$64.2M
4
MA icon
Mastercard
MA
+$60.4M
5
MMM icon
3M
MMM
+$55.1M

Sector Composition

Rank Sector Weight
1 Technology 33.32%
2 Healthcare 19.18%
3 Consumer Discretionary 12.27%
4 Financials 8.16%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
51
Union Pacific
UNP
$169B
$116M 0.41%
571,794
+23,648
+4% +$5.15M
APTV icon
52
Aptiv
APTV
$9.09B
$116M 0.41%
1,179,021
-66,110
-5% -$6.83M
KO icon
53
Coca-Cola
KO
$381B
$114M 0.4%
2,044,919
-184,618
-8% -$11.1M
TSM icon
54
TSMC
TSM
$2.15T
$114M 0.4%
1,316,875
-133,681
-9% -$12.6M
BIIB icon
55
Biogen
BIIB
$31.7B
$113M 0.4%
441,249
+1,047
+0.2% +$280K
TER icon
56
Teradyne
TER
$51.3B
$113M 0.4%
1,121,824
-41,670
-4% -$4.39M
ROP icon
57
Roper Technologies
ROP
$37.9B
$113M 0.4%
232,625
+6,652
+3% +$3.26M
VEEV icon
58
Veeva Systems
VEEV
$43.1B
$110M 0.38%
538,277
+14,365
+3% +$2.89M
ACN icon
59
Accenture
ACN
$119B
$109M 0.38%
354,297
-56,230
-14% -$17.7M
WDAY icon
60
Workday
WDAY
$46.3B
$108M 0.38%
502,874
+2,449
+0.5% +$568K
TEL icon
61
TE Connectivity
TEL
$58.6B
$108M 0.38%
874,583
-84,604
-9% -$11.3M
GPN icon
62
Global Payments
GPN
$23.5B
$107M 0.38%
924,668
-91,480
-9% -$10.9M
PCAR icon
63
PACCAR
PCAR
$64B
$106M 0.37%
1,244,154
+228,587
+23% +$19.4M
UPS icon
64
United Parcel Service
UPS
$86.7B
$105M 0.37%
674,287
+51,286
+8% +$8.85M
EW icon
65
Edwards Lifesciences
EW
$49.2B
$102M 0.36%
1,468,892
-348,482
-19% -$28M
VRTX icon
66
Vertex Pharmaceuticals
VRTX
$130B
$99.3M 0.35%
285,675
+10,329
+4% +$3.61M
WCN
67
Waste Connections
WCN
$40.4B
$97.8M 0.34%
727,862
-42,431
-6% -$5.94M
HD icon
68
Home Depot
HD
$305B
$97.5M 0.34%
322,663
-66,574
-17% -$21.4M
DHR icon
69
Danaher
DHR
$145B
$97.3M 0.34%
499,073
+44,895
+10% +$10M
AXNX
70
DELISTED
Axonics, Inc. Common Stock
AXNX
$97M 0.34%
1,728,111
+67,305
+4% +$3.79M
REGN icon
71
Regeneron Pharmaceuticals
REGN
$79.8B
$93.9M 0.33%
114,041
+685
+0.6% +$538K
MCO icon
72
Moody's
MCO
$81.3B
$92.9M 0.33%
293,697
+33,400
+13% +$11.4M
NEE icon
73
NextEra Energy
NEE
$169B
$92.8M 0.33%
1,620,620
-17,300
-1% -$1.2M
RSG icon
74
Republic Services
RSG
$68.8B
$91.4M 0.32%
641,093
-11,854
-2% -$1.76M
MCHP icon
75
Microchip Technology
MCHP
$38.6B
$90.7M 0.32%
1,162,044
-349,279
-23% -$29.2M

Similar funds

Axa's Q3 2023 Portfolio in Review

As of Q3 2023, Axa held 1,182 positions worth $28.5B, down 5.5% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa's Q3 2023 filing shows 104 new, 354 increased, 497 reduced and 123 closed positions. Its largest new stake was Invesco: 1,126,202 shares worth $16.4M. The largest sale was Silicon Laboratories, an estimated $84.9M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2023 buy was Invesco: 1,126,202 shares worth $16.4M.
  • Axa added most to Applied Materials in Q3 2023, an estimated $94.3M increase.
  • Axa's biggest Q3 2023 reduction was Silicon Laboratories, cutting an estimated $84.9M.
  • Axa fully exited Life Storage, Inc. in Q3 2023, selling an estimated $19.3M.
  • Axa's ten largest holdings make up 23% of its $28.5B portfolio in Q3 2023.
  • Axa opened 104 new positions and closed 123 in Q3 2023.
  • Axa's portfolio value fell 5.5% quarter-over-quarter to $28.5B.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.